ALT5 Sigma Corporation Issues Material Update: Entry into Stock Exchange Agreement and Pre-Funded Warrant Issuance

Key Highlights from the Report

• ALT5 Sigma Corporation has entered into a Material Definitive Agreement (the “Stock Exchange Agreement” or SEA), which includes the issuance of Common Stock and Pre-Funded Warrants.
• The transaction involves various tranches of equity securities subject to lock-up and leak-out provisions, which may impact trading liquidity and future share supply.
• Pre-Funded Warrants have been issued with a nominal exercise price of \$0.001 per share, having already been largely pre-paid at \$0.9471 per share. These warrants are subject to specific exercise and lock-up terms.
• The Company is not obligated to register any of the shares issued under the SEA, including Common Stock or shares underlying the Pre-Funded Warrants.
• Detailed restrictions on transfer and sale (“leak-out” provisions) for both Common Stock and Pre-Funded Warrants are in place, potentially influencing market dynamics and future price action.
• The agreements contain anti-dilution (adjustment) protections for warrant holders, potentially increasing the number of shares issuable in the event of stock splits, dividends, or recapitalizations.
• All disputes related to the agreements, including exercise price calculations, are subject to binding arbitration under New York law.
• The Company has committed to keeping a reserve of at least three times the number of shares necessary to cover all outstanding Pre-Funded Warrants.

Details Investors Must Note

1. Stock Exchange Agreement and Equity Issuance

The Company has entered into a Stock Exchange Agreement covering the issuance of Common Stock and Pre-Funded Warrants. The initial issuance of shares was conducted as a private placement under Section 4(a)(2) of the Securities Act of 1933. The details of these agreements are incorporated by reference in the 8-K filing, with full texts available as exhibits.

The shares issued under this agreement, including warrants, are subject to a 24-month lock-up period. Releases of 25% of the shares occur every six months, starting April 20, 2026, for the initial stock, and on the respective issuance dates for warrant stock.

2. Leak-Out and Lock-Up Provisions

• After the expiration of the lock-up period, holders of “leak-out” shares and Pre-Funded Warrant Stock can sell up to 10% of the average daily trading volume (as reported on nasdaq.com) for the preceding 20 days, per day. This is a “use it or lose it” provision—unsold allocation does not carry over.
• If shares are transferred to a third party, the new holder must agree to the same leak-out rules, and their sales are aggregated with those of the original holder.
• The Company is not required to register these shares, which may affect liquidity and the ability to resell the securities.

3. Pre-Funded Warrants—Terms and Adjustments

• Each Pre-Funded Warrant is exercisable for Common Stock at a nominal price of \$0.001 per share, with the main consideration already paid up front. No additional consideration (other than the nominal exercise price) is required to exercise the warrants.
• Warrant holders may use a cashless exercise mechanism after six months if no effective registration statement is available, using a formula involving the average VWAP over the preceding five days, potentially allowing the holder to receive more shares if the market price is favorable.
• Anti-dilution adjustments are included, so if the Company does a stock split, dividend, or recapitalization, the number of shares issuable on exercise of the warrants will be adjusted accordingly.
• The Company must always reserve at least three times the maximum number of shares required to cover all outstanding Pre-Funded Warrants, and must act to increase its authorized share capital if necessary.
• The warrants are freely transferable except as otherwise restricted by the SEA.

4. Dispute Resolution and Other Shareholder Rights

• All disputes regarding exercise price, calculation of shares, or material terms are subject to binding arbitration in New York, with procedures outlined in the agreement.
• The Company is required to provide prompt notice to holders of any actions affecting the warrants, including adjustments, significant transactions, or breaches of the agreements.
• In the event of a Fundamental Transaction (e.g., merger, asset sale, reorganization), the holder may be entitled to alternate consideration, but if the Company is delisted and shareholders primarily receive cash or marketable securities, the right is limited to the alternate consideration.
• The Company is prohibited from taking actions which would limit the ability to exercise the warrants or increase the par value above the exercise price.

Potential Price-Sensitive and Shareholder-Relevant Issues

• Potential Dilution: The issuance of shares and Pre-Funded Warrants, especially with anti-dilution protection, may significantly increase the number of outstanding shares, affecting existing shareholders’ ownership percentage and potentially depressing the share price if exercised and sold into the market.
• Leak-Out Sales: The structured release of shares for sale into the public market could create ongoing selling pressure, especially given the relatively high daily limit (10% of average trading volume).
• Lack of Registration: Since these shares are unregistered, liquidity may be limited, but the agreements allow for cashless exercise and transferability, which could lead to complex trading dynamics.
• Exercise Price and Adjustments: The nominal exercise price and possibility for downward adjustments means warrants are almost always “in the money,” potentially incentivizing rapid exercise and sale if market conditions are favorable.
• Obligation to Increase Authorized Shares: If the Company runs out of authorized shares, it must call a shareholder meeting to increase the share count, which may signal further dilution.
• Pre-Funded Structure: Most of the exercise price is already paid, removing a primary financial barrier to rapid exercise and sale of these warrants.

Conclusion

The entry into the Stock Exchange Agreement and the issuance of Pre-Funded Warrants represent significant corporate actions for ALT5 Sigma Corporation. These measures could have a substantial impact on the Company’s capital structure, liquidity, and share price. Investors should carefully monitor further disclosures and potential future exercises or sales under these agreements, as well as any shareholder meetings related to increasing authorized share capital.

Disclaimer: This article is for informational purposes only and does not constitute investment advice. Investors should consult their own advisors and review the full regulatory filings with the SEC for a complete understanding of the risks and implications of these corporate actions. The information presented is based on the Company’s Form 8-K and attached exhibits as of the date of the filing.

View ALT5 Sigma Corp Historical chart here